Serial 98414874
Live / Allowed — Notice of allowance issued (as of 27 May 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 21 Feb 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98414874
- Mark type
- Design / logo
- Filed
- 21 Feb 2024
- Published for opposition
- 01 Apr 2025
- Attorney of record
- Danielle Rivera
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disorders, digital ulcers
- Class 010 — Medical apparatus: Medical apparatus for introducing pharmaceutical preparations into the human body; medical devices for the treatment of cancer
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 20 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 20 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 27 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Apr 2025 — PUBLISHED FOR OPPOSITION
- 26 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 05 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Oct 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Oct 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Oct 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Sept 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Sept 2024 — NON-FINAL ACTION E-MAILED
- 11 Sept 2024 — NON-FINAL ACTION WRITTEN
- 11 Sept 2024 — ASSIGNED TO EXAMINER
- 27 Jun 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED